Market Cap 7.15M
Revenue (ttm) 0.00
Net Income (ttm) -17.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.02
Volume 4,200
Avg Vol 36,229
Day's Range N/A - N/A
Shares Out 1.15M
Stochastic %K 78%
Beta 0.64
Analysts Sell
Price Target $27.00

Company Profile

Akari Therapeutics, Plc, an oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, colon, and prostate. Its payloads in...

Industry: Biotechnology
Sector: Healthcare
Phone: 929 274 7510
Fax: 929 274 7553
Address:
22 Boston Wharf Road, Floor 7, Boston, United States
Nick1971
Nick1971 May. 9 at 12:08 AM
$AKTX I sold every share before split and opened a new account with $2,000 Made this in last 2wks trading with @smartertrader I’ll never waste my time on a bio stock again unless scalp trade on a run. This stock is forever dead to me and I made 10x my loss here. I did enjoy the fun with the longs here
0 · Reply
topstockalerts
topstockalerts May. 5 at 11:31 PM
After Hours Top Gainers PT2 $COMP $SMCI $FLEX $CYPH $AKTX
0 · Reply
Amricanopyscho
Amricanopyscho May. 5 at 10:42 PM
$AKTX went on low volume
0 · Reply
MTN
MTN May. 5 at 3:04 PM
$AKTX still needs over a 3000% run up to make holders of the last few years whole. Just break even.
0 · Reply
MTN
MTN May. 5 at 3:03 PM
$AKTX just trying to sucker in buyers. Until they announce a major partnership, this is just MMs and traders trying to take your hard earned money. Don't believe me? Look at the chart.
0 · Reply
KayJ_
KayJ_ May. 4 at 8:57 PM
0 · Reply
coachmc
coachmc Apr. 29 at 6:27 PM
$AKTX the volume here is laughable , also the MC and spread
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 28 at 1:34 PM
$AKTX Current Stock Price: $5.60
0 · Reply
MTN
MTN Apr. 27 at 3:37 PM
$AKTX -$2,114.55 (99.74%) down from the ATH. Don't waste your time here.
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 27 at 12:35 PM
$AKTX Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload
0 · Reply
Latest News on AKTX
Akari Therapeutics downgraded to Hold from Buy at Maxim

2026-04-09T13:05:47.000Z - 4 weeks ago

Akari Therapeutics downgraded to Hold from Buy at Maxim


Akari Therapeutics downgraded to Hold from Buy at Maxim

2026-04-08T12:08:04.000Z - 4 weeks ago

Akari Therapeutics downgraded to Hold from Buy at Maxim


Akari Therapeutics trading halted, news pending

2026-03-30T23:51:11.000Z - 5 weeks ago

Akari Therapeutics trading halted, news pending


Akari Therapeutics Announces ADS Ratio Change

Mar 17, 2026, 4:30 PM EDT - 7 weeks ago

Akari Therapeutics Announces ADS Ratio Change


Akari Therapeutics appoints Olga Anczukow to SAB

2026-02-23T13:53:01.000Z - 2 months ago

Akari Therapeutics appoints Olga Anczukow to SAB


Akari Therapeutics, Transcript: Study update

Feb 10, 2026, 7:00 PM EST - 3 months ago

Akari Therapeutics, Transcript: Study update


Akari Therapeutics files patent covering AKTX-102

2026-01-26T13:51:30.000Z - 3 months ago

Akari Therapeutics files patent covering AKTX-102


Akari Therapeutics to Present at the 2026 Biotech Showcase

Jan 8, 2026, 9:15 AM EST - 4 months ago

Akari Therapeutics to Present at the 2026 Biotech Showcase


Akari Therapeutics initiated with a Buy at Ladenburg

2026-01-05T11:40:46.000Z - 4 months ago

Akari Therapeutics initiated with a Buy at Ladenburg


Akari Therapeutics initiates GMP manufacturing of AKTX-101

2025-12-23T13:40:49.000Z - 4 months ago

Akari Therapeutics initiates GMP manufacturing of AKTX-101


Akari Therapeutics announces $5M financing

2025-12-16T14:35:52.000Z - 5 months ago

Akari Therapeutics announces $5M financing


Akari Therapeutics announces preclinical data on AKTX-101

2025-12-09T13:46:08.000Z - 5 months ago

Akari Therapeutics announces preclinical data on AKTX-101


Akari Therapeutics appoints Farag as interim CFO

2025-11-18T14:44:50.000Z - 6 months ago

Akari Therapeutics appoints Farag as interim CFO


Akari Therapeutics Announces Launch of CEO Corner Platform

Oct 22, 2025, 9:05 AM EDT - 7 months ago

Akari Therapeutics Announces Launch of CEO Corner Platform


Akari Therapeutics Announces Key Leadership Appointments

Dec 18, 2024, 8:51 AM EST - 1 year ago

Akari Therapeutics Announces Key Leadership Appointments


Nick1971
Nick1971 May. 9 at 12:08 AM
$AKTX I sold every share before split and opened a new account with $2,000 Made this in last 2wks trading with @smartertrader I’ll never waste my time on a bio stock again unless scalp trade on a run. This stock is forever dead to me and I made 10x my loss here. I did enjoy the fun with the longs here
0 · Reply
topstockalerts
topstockalerts May. 5 at 11:31 PM
After Hours Top Gainers PT2 $COMP $SMCI $FLEX $CYPH $AKTX
0 · Reply
Amricanopyscho
Amricanopyscho May. 5 at 10:42 PM
$AKTX went on low volume
0 · Reply
MTN
MTN May. 5 at 3:04 PM
$AKTX still needs over a 3000% run up to make holders of the last few years whole. Just break even.
0 · Reply
MTN
MTN May. 5 at 3:03 PM
$AKTX just trying to sucker in buyers. Until they announce a major partnership, this is just MMs and traders trying to take your hard earned money. Don't believe me? Look at the chart.
0 · Reply
KayJ_
KayJ_ May. 4 at 8:57 PM
0 · Reply
coachmc
coachmc Apr. 29 at 6:27 PM
$AKTX the volume here is laughable , also the MC and spread
0 · Reply
BillionerOfKing
BillionerOfKing Apr. 28 at 1:34 PM
$AKTX Current Stock Price: $5.60
0 · Reply
MTN
MTN Apr. 27 at 3:37 PM
$AKTX -$2,114.55 (99.74%) down from the ATH. Don't waste your time here.
0 · Reply
Stock_Catcher
Stock_Catcher Apr. 27 at 12:35 PM
$AKTX Akari Therapeutics Secures Australian Patent Approval, Further Expanding Global Protection of Its Proprietary PH1 RNA Splicing Modulator ADC Payload
0 · Reply
DARKP00L
DARKP00L Apr. 21 at 1:14 PM
$AKTX 09:01 on Apr. 21 2026 Akari Therapeutics Announces Abstract Acceptance For Online Publication At American Society Of Clinical Oncology Annual Meeting 2026 #tradeideas
0 · Reply
MTN
MTN Apr. 20 at 5:18 PM
$AKTX holders from a few years ago would need over 3000% run up just to break even. Save your time, money and headaches, let these losers go bankrupt on their own dime, not yours.
0 · Reply
MTN
MTN Apr. 20 at 5:17 PM
$AKTX More bs pre-clinical data - that no large pharma will pay for....again, story of AKTX. Promising pipeline, huge patent library, nothing to show for it but burning hundreds of millions - don't believe me? Look at their 8k or zoom out on the share price. Insane to think this was once viewed the same way $VKTX was.
1 · Reply
BecauseOfScout
BecauseOfScout Apr. 20 at 5:13 PM
$AKTX Interesting
0 · Reply
focafoca99
focafoca99 Apr. 20 at 1:34 PM
$AKTX reported positive preclinical data for AKTX-101, highlighting differentiated cytotoxicity for its TROP2 ADC payload targeting RNA splicing. https://www.rapidticker.com/news/aktx-akari-therapeutics-reports-positive-preclinical-e36ccb
0 · Reply
durocali
durocali Apr. 20 at 12:52 PM
$AKTX expected bigger positive impact on the stock with today's reporting. typical sell the news action or something underneath here?
0 · Reply
Sashko2018
Sashko2018 Apr. 20 at 12:51 PM
$AKTX 150$
1 · Reply
Sashko2018
Sashko2018 Apr. 20 at 12:51 PM
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 20 at 12:44 PM
$AKTX (-4.8% pre) Bladder, lung and breast models show Akari drug beats TROP2 rivals https://ooc.bz/l/99270
0 · Reply
scolii
scolii Apr. 20 at 12:40 PM
$AKTX this stopped me from buying in on this news. thanks. shitter hit red in 3 minutes
0 · Reply
DARKP00L
DARKP00L Apr. 20 at 12:39 PM
$AKTX 08:36 on Apr. 20 2026 Akari Therapeutics' AKTX-101 Shows Superior Preclinical Potency Versus Leading TROP2 ADCs Across Bladder, Lung, And Breast Cancer Models #tradeideas
0 · Reply